Astute Medical Logo
Innovative biomarkers.  Smarter healthcare.

Novel Biomarkers for Acute Medica Problems Identified. Validated

 

Astute Medical is committed to improving patient outcomes through the identification and validation of unique, new biomarkers. Our measurement methods help rapidly assess high-risk acute medical problems and diseases. By incorporating useful clinical tools, we help health care professionals more readily perform risk assessment for elderly and critically ill patients. And because our tools produce test results for risk assessment within minutes, they position physicians to provide rapid, accurate and life-saving responses.

The Astute Medical Video


Astute Involvement

Interested in learning more about our processes for immunoassay development of new biomarkers of acute medical conditions and diseases? We welcome collaboration, particularly with peers who share our commitment to improving clinical tools for acute conditions. To get involved, our contact information is listed.

Astute Medical, Inc.
3550 General Atomics Court
Building 02/620
San Diego, CA 92121, USA
Phone: +1 (858) 500-7000
Fax: +1 (858) 882-0449

Astute Medical France, SAS
Tour de l’Horloge
4 Place Louis Armand
75603 PARIS CEDEX 12
Téléphone: +33 1 72 76 25 38
Télécopie: +33 1 72 76 25 39

 

Astute Careers
Do you have medical industry experience or enjoy researching new biomarkers of acute medical problems? Are you a loyal, self-motivated professional who sees the glaring need for better clinical tools in the ICU? If so, you may be an excellent fit to join the Astute Medical mission. To find out, read about our current career opportunities.

©2017 Astute Medical, Inc. Astute Medical®, the AM logo, Astute140®NephroCheck®, the NephroCheck® logo, and AKIRisk® are registered trademarks of Astute Medical, Inc. in the United States. For information regarding trademarks and other intellectual property applicable to this product, including international trademarks, please see AstuteMedical.com/about/intellectualproperty. PN 0090 Rev F 2015/07/28